Mitigation of Rheumatic Arthritis in a Rat Model Via Transdermal Delivery of Dapoxetine HCl Amalgamated As a Nanoplatform: In Vitro and in Vivo Assessment

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2020 Mar 20

PMID 32189966

Citations 11

Authors

Heba Farouk Salem

Mohamed Mahmoud Nafady

Rasha Mostafa Kharshoum

Omnia Ahmed Abd El-Ghafar

Hanan Osman Farouk

Affiliations

Soon will be listed here.

Abstract

Purpose: Dapoxetine HCl (DH), a selective serotonin reuptake inhibitor, may be useful for the treatment of rheumatic arthritis (RA). The purpose of this study was to investigate the therapeutic efficacy of transdermal delivery of DH in transethosome nanovesicles (TENVs). This novel delivery of DH may overcome the drawbacks associated with orally administered DH and improve patient compliance.

Methods: DH-TENV formulations were prepared using an injection- sonication method and optimized using a 3 Box-Behnken-design with Design Expert software. The TENV formulations were assessed for entrapment efficiency (EE-%), vesicle size, zeta potential, in vitro DH release, and skin permeation. The tolerability of the optimized DH-TENV gel was investigated using a rat skin irritation test. A pharmacokinetic analysis of the optimized DH-TENV gel was also conducted in rats. Moreover, the anti-RA activity of the optimized DH-TENV gel was assessed based on the RA-specific marker anti-cyclic cirtullinated peptide antibody (anti-CCP), the cartilage destruction marker cartilage oligomeric matrix protein (COMP) and the inflammatory marker interleukin-6 (IL-6). Level of tissue receptor activator of nuclear factor kappa-Β ligand (RANKL) were also assessed.

Results: The optimized DH-TENV formulation involved spherical nanovesicles that had an appropriate EE- % and skin permeation characteristic. The DH-TENV gel was well tolerated by rats. The pharmacokinetics analysis showed that the optimized DH-TENV gel boosted the bioavailability of the DH by 2.42- and 4.16-fold compared to the oral DH solution and the control DH gel, respectively. Moreover, it significantly reduced the serum anti-CCP, COMP and IL-6 levels and decreased the RANKL levels. Furthermore, the DH-TENV gel attenuated histopathological changes by almost normalizing the articular surface and synovial fluid.

Conclusion: The results indicate that DH-TENVs can improve transdermal delivery of DH and thereby alleviate RA.

Citing Articles

Enhancing the Therapeutic Effect and Bioavailability of Irradiated Silver Nanoparticle-Capped Chitosan-Coated Rosuvastatin Calcium Nanovesicles for the Treatment of Liver Cancer.

Mahmoud T, Abdelfatah M, Omar M, Hasan O, Wali S, El-Mofty M Pharmaceutics. 2025; 17(1).

PMID: 39861720 PMC: 11769262. DOI: 10.3390/pharmaceutics17010072.

Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications.

Rani R, Raina N, Sharma A, Kumar P, Tulli H, Gupta M Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(10):2287-2310.

PMID: 37166463 DOI: 10.1007/s00210-023-02514-5.

Brain Targeting of Citicoline Sodium via Hyaluronic Acid-Decorated Novel Nano-Transbilosomes for Mitigation of Alzheimer's Disease in a Rat Model: Formulation, Optimization, in vitro and in vivo Assessment.

AbouElhassan K, Sarhan H, Hussein A, Taye A, Ahmed Y, Safwat M Int J Nanomedicine. 2022; 17:6347-6376.

PMID: 36540376 PMC: 9759982. DOI: 10.2147/IJN.S381353.

Novel Bile Salt Stabilized Vesicles-Mediated Effective Topical Delivery of Diclofenac Sodium: A New Therapeutic Approach for Pain and Inflammation.

Mahmoud T, Nafady M, Farouk H, Mahmoud D, Ahmed Y, Zaki R Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145327 PMC: 9506322. DOI: 10.3390/ph15091106.

Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation.

Ahmed Y, Orfali R, Hamad D, Rateb M, Farouk H Pharmaceutics. 2022; 14(8).

PMID: 35893792 PMC: 9394333. DOI: 10.3390/pharmaceutics14081536.

References

Hibi M, Nakajima K, Hirano T . IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med (Berl). 1996; 74(1):1-12. DOI: 10.1007/BF00202068. View

Shah S, Ashtikar M, Jain A, Makhija D, Nikam Y, Gude R . LeciPlex, invasomes, and liposomes: A skin penetration study. Int J Pharm. 2015; 490(1-2):391-403. DOI: 10.1016/j.ijpharm.2015.05.042. View

Xia Z, Depierre J, Nassberger L . Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 1996; 34(1):27-37. DOI: 10.1016/0162-3109(96)00111-7. View

Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B . Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004; 13(9):635-8. DOI: 10.1191/0961203304lu1094oa. View

Moawad F, Ali A, Salem H . Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance. Drug Deliv. 2017; 24(1):252-260. PMC: 8241079. DOI: 10.1080/10717544.2016.1245369. View

Makino K, Yamada T, Kimura M, Oka T, Ohshima H, Kondo T . Temperature- and ionic strength-induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data. Biophys Chem. 1991; 41(2):175-83. DOI: 10.1016/0301-4622(91)80017-l. View

Durairaj H, Steury M, Parameswaran N . Paroxetine differentially modulates LPS-induced TNFα and IL-6 production in mouse macrophages. Int Immunopharmacol. 2015; 25(2):485-92. PMC: 4373999. DOI: 10.1016/j.intimp.2015.02.029. View

Ahmad A, Alkharfy K, Wani T, Raish M . Application of Box-Behnken design for ultrasonic-assisted extraction of polysaccharides from Paeonia emodi. Int J Biol Macromol. 2014; 72:990-7. DOI: 10.1016/j.ijbiomac.2014.10.011. View

Fonseka T, McIntyre R, Soczynska J, Kennedy S . Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opin Investig Drugs. 2015; 24(4):459-75. DOI: 10.1517/13543784.2014.998334. View

10.

Li J, Zhu N, Zhu J, Zhang W, Zhang H, Wang Q . Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol. Med Sci Monit. 2015; 21:3298-310. PMC: 4632989. DOI: 10.12659/msm.894484. View

11.

Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare O . Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv. 2005; 2(2):143-53. DOI: 10.2174/1567201053585985. View

12.

Lampropoulos C, Orfanos P, Bournia V, Karatsourakis T, Mavragani C, Pikazis D . Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol. 2015; 33(2):216-24. View

13.

Wendling D, Racadot E, Wijdenes J . Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol. 1993; 20(2):259-62. View

14.

El-Menshawe S, Ali A, Halawa A, Srag El-Din A . A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization. Drug Des Devel Ther. 2017; 11:3377-3388. PMC: 5713695. DOI: 10.2147/DDDT.S144652. View

15.

Fouad S, Shamma R, Basalious E, El-Nabarawi M, Tayel S . Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation. Drug Dev Ind Pharm. 2018; 44(9):1443-1450. DOI: 10.1080/03639045.2018.1459675. View

16.

Verma P, Pathak K . Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 2011; 8(4):489-96. DOI: 10.1016/j.nano.2011.07.004. View

17.

Abdulbaqi I, Darwis Y, Abou Assi R, Khan N . Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug Des Devel Ther. 2018; 12:795-813. PMC: 5898596. DOI: 10.2147/DDDT.S158018. View

18.

ElMeshad A, Mohsen A . Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. 2014; 23(7):2115-2123. DOI: 10.3109/10717544.2014.942811. View

19.

Bhalekar M, Upadhaya P, Madgulkar A . Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-α ELISA. Eur J Pharm Sci. 2016; 84:1-8. DOI: 10.1016/j.ejps.2016.01.009. View

20.

Lopez-Pinto J, Gonzalez-Rodriguez M, Rabasco A . Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 2005; 298(1):1-12. DOI: 10.1016/j.ijpharm.2005.02.021. View